Summit Partners Public Asset Management’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-377,152
Closed -$17.9M 133
2025
Q3
$17.9M Buy
377,152
+10,155
+3% +$492K 0.58% 74
2025
Q2
$19.6M Sell
366,997
-213,003
-37% -$9.68M 0.76% 63
2025
Q1
$23.5M Buy
+580,000
New +$24.6M 1.13% 60

Other funds holding AKRO